Skip to main content
. 2004 Nov;48(11):4476–4478. doi: 10.1128/AAC.48.11.4476-4478.2004

TABLE 1.

Plasma indinavir PK parameters over 12 h for three different dosesa

Patient or parameter Cmax (ng/ml)
Cmin
AUC0-12b (ng · h/ml)
C0h
C12h
800/100c 600/100 400/100 800/100 600/100 400/100 800/100 600/100 400/100 800/100 600/100 400/100
1 7,965 4,348 2,375 1,317 295 213 447 212 170 45,467 22,589 12,726
2 7,336 4,881 2,986 1,157 583 336 501 283 105 43,745 26,464 14,237
3 7,596 4,909 3,120 510 287 289 172 108 124 35,691 20,842 14,515
4 8,149 7,789 2,939 820 228 404 380 199 135 47,944 26,249 16,234
5 17,316 11,696 5,863 1,565 1,242 370 964 357 303 85,640 52,516 25,954
Median 7,965 4,909 2,986 1,157 295 336 447 212 135 45,467 26,249 14,515
Mean 9,672 6,725 3,457 1,074 527 322 493 232 167 51,697 29,732 16,733
SD 4,285 3,090 1,375 415 423 74 291 94 79 19,522 12,961 5,303
a

P values for comparisons of parameters were all less than 0.01.

b

AUC, area under the indinavir pharmacokinetic curve.

c

Doses (given twice daily) are given in milligrams of indinavir/milligrams of ritonavir.